Literature DB >> 27382226

Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles.

Shilpa Saple1, Mukesh Agrawal1, Simi Kawar1.   

Abstract

Antagonist cycles have an inherent issue of lack of flexibility. As a result where batching of cycles is desired, it is not the preferred protocol in ART cycles. There is also the limitation of ovarian response in antagonist cycle due to the size heterogenesities of antral follicles at the start of stimulation. Among the different options available, use of estrogen in the luteal phase of the preceding cycle has definitely shown benefits with regard to better control of cycle as well as synchronization of follicles available for stimulation. The article gives a detailed analysis of the different options available for timing the egg collection in antagonist cycles, the advantages and drawbacks, and the method of use of estrogen. Whereas in the majority of the trials where estrogen pretreatment was used, the goal of scheduling of egg collection was definitely achieved, increased duration and dose of gonadotropin stimulation were required. There was definite advantage of higher oocyte yield in these cycles. The possibility of premature LH rise later during stimulation and subsequent poor implantation in these cycles has to be further evaluated. Nevertheless, batching of patient friendly antagonist cycles can be effectively possible by use of precycle estrogen treatment.

Entities:  

Keywords:  Antagonist cycle; Precycle estrogen; Synchronization

Year:  2016        PMID: 27382226      PMCID: PMC4912497          DOI: 10.1007/s13224-016-0877-z

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  28 in total

1.  Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vitro fertilization.

Authors:  Eun Mi Chang; Ji Eun Han; Hyung Jae Won; You Shin Kim; Tae Ki Yoon; Woo Sik Lee
Journal:  J Assist Reprod Genet       Date:  2011-12-08       Impact factor: 3.412

2.  Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists.

Authors:  Renato Fanchin; Laurent Salomon; Altina Castelo-Branco; François Olivennes; Nelly Frydman; René Frydman
Journal:  Hum Reprod       Date:  2003-12       Impact factor: 6.918

3.  Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol.

Authors:  I Cédrin-Durnerin; B Bständig; I Parneix; V Bied-Damon; C Avril; C Decanter; J N Hugues
Journal:  Hum Reprod       Date:  2006-08-26       Impact factor: 6.918

4.  Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes.

Authors:  K P Tremellen; M Lane
Journal:  Hum Reprod       Date:  2010-03-09       Impact factor: 6.918

5.  Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized trial.

Authors:  Isabelle Cédrin-Durnerin; Anne Guivarc'h-Levêque; Jean-Noël Hugues
Journal:  Fertil Steril       Date:  2012-03-28       Impact factor: 7.329

6.  A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment.

Authors:  Alice D Domar; Kristin Smith; Lisa Conboy; Marie Iannone; Michael Alper
Journal:  Fertil Steril       Date:  2009-07-09       Impact factor: 7.329

7.  IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.

Authors:  Hong Ye; Guo-ning Huang; Ping-hong Zeng; Li Pei
Journal:  J Assist Reprod Genet       Date:  2009-02-19       Impact factor: 3.412

8.  Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients.

Authors:  A K Schröder; A Katalinic; K Diedrich; M Ludwig
Journal:  Reprod Biomed Online       Date:  2004-05       Impact factor: 3.828

Review 9.  Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis.

Authors:  George Griesinger; Christos A Venetis; Tanja Marx; Klaus Diedrich; Basil C Tarlatzis; Efstratios M Kolibianakis
Journal:  Fertil Steril       Date:  2007-12-03       Impact factor: 7.329

10.  Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial.

Authors:  Erik E Hauzman; Azucena Zapata; Alfonso Bermejo; Carlos Iglesias; Antonio Pellicer; Juan A Garcia-Velasco
Journal:  Reprod Biol Endocrinol       Date:  2013-09-28       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.